tiprankstipranks
Crinetics Pharmaceuticals (CRNX)
NASDAQ:CRNX
US Market

Crinetics Pharmaceuticals (CRNX) Stock Investors

413 Followers
Based on 729,234 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

<0.1% of all portfolios hold CRNX
On average, investors allocate 3.30% of their portfolios to CRNX
The average holding size of this company in investors' portfolios.

Investor Sentiment

Very Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on the activity of 729,234 investors in the recent quarter
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CRNX

0.3%
Last 7
Days
8.0%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CRNX, out of 729,234 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CRNX Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Reduced
0.23%
$44.97
Opened
0.37%
$34.75
Increased
7.66%
$29.99
Opened
1.07%
$31.81
Opened
0.00%
$30.22
Reduced
1.68%
$43.76
Opened
2.54%
$40.47
Based on the activity of 13,706 investors who made their portfolios public
The table shows changes in CRNX in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CRNX Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Coherus Biosciences
2.64%
-1.06%
-8.48%
234.94M
Healthcare
Merck & Company
4.14%
-0.66%
-1.47%
318.56B
Healthcare
Marvell
4.79%
-0.11%
+5.31%
53.80B
Technology
ServiceNow
4.02%
-1.47%
-2.45%
146.35B
Technology
Micron
5.67%
-0.08%
+12.41%
118.23B
Technology
GE Aerospace
5.50%
+0.90%
+6.06%
161.87B
Industrials
Trade Desk
4.69%
-1.64%
-4.46%
37.79B
Technology
Block
4.46%
-0.90%
-7.52%
43.36B
Technology
Mastercard
4.78%
-0.17%
-2.07%
424.83B
Financial
Riot Platforms
4.94%
-0.10%
-1.04%
2.31B
Financial
Based on the activity of 729,234 active portfolios
Open your Smart Portfolio

CRNX Investor Analysis

CRNX investors under 35

Under 35

0.0%
Last 30 days
Holdings Change
6.0%
of CRNX holders
are under 35
Average Segment Performance
Average P/E Ratio55.48
Beta6.58
Dividend Yield6.31%
CRNX investors between 35–55

Between 35–55

0.0%
Last 30 days
Holdings Change
52.0%
of CRNX holders
are between 35–55
Average Segment Performance
Average P/E Ratio59.75
Beta11.38
Dividend Yield17.85%
CRNX investors over 55

Over 55

0.0%
Last 30 days
Holdings Change
42.0%
of CRNX holders
are over 55
Average Segment Performance
Average P/E Ratio50.99
Beta4.10
Dividend Yield29.58%
Overview of age group and performance of CRNX stock investors
See who invests in CRNX according to age group and performance.

FAQ

How many retail Investors hold CRNX?
<0.1% of TipRanks' retail investors hold CRNX in their portfolios.
    What is CRNX Investor Sentiment?
    CRNX’s Investor Sentiment is Very Positive.
      What percentage of retail investors changed their holding of CRNX in the last 7 days?
      ▼ 0.3% of TipRanks' retail investors changed their holding of CRNX in the last 7 days.
        What percentage of retail investors changed their holding of CRNX in the last 30 days?
        ▲ 8.0% of TipRanks' retail investors changed their holding of CRNX in the last 30 days.
          What is the average age of retail investors who hold CRNX?
          The average age of CRNX Holders is between 35–55.
            What other stocks have CRNX investors also bought?
            CRNX Investors also bought CHRS, MRK, MRVL, NOW, MU, GE, TTD, SQ, MA, RIOT.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              CORCencora
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis